Oscar Global Share Price
22.68+0.00 (+0.00%)
+90.59% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Oscar Global Share Price
22.68+0.00 (+0.00%)
+90.59% past 1 Year
Technical meters

No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Oscar Global Share Price
22.68+0.00 (+0.00%)
+90.59% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly

No results found
Bulk & block deals

No results found
Insider trading & SAST

No results found
Oscar Global Share Price
22.68+0.00 (+0.00%)
+90.59% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Oscar Global Share Price
22.68+0.00 (+0.00%)
+90.59% past 1 Year
Corporate filings & documents

No corporate filings & documents found
Oscar Global Share Price
22.68+0.00 (+0.00%)
+90.59% past 1 Year
News
Iran Signals Strait Of Hormuz Reopening If US Eases Military Pressure
Broader Market
RITES Secures Contract Valued At Rs 155 Crores
Equity
RITES
Tempsens Instruments expects new capacity utilization by fiscal year 2030
Equity
TEMPSENS
Tempsens Instruments Announces Four New Projects With Rs 500 Crores Revenue Potential
Equity
TEMPSENS
Tempsens Instruments Expects Profit Growth To Match Revenue Growth By Fiscal Year 2027
Equity
TEMPSENS
Tempsens Instruments Expects Sustained Revenue Growth With Stable Margins Ahead
Equity
TEMPSENS
Tempsens clarifies outlook and capacity revenue potential is indicative
Equity
TEMPSENS
Symbiotec Pharmalab Signs Term Sheet With Large US Pharma Company
Equity
SYMBIOTEC
Symbiotec Pharmalab maintains API gross margin guidance near 60 percent
Equity
SYMBIOTEC
Symbiotec Pharmalab Plans Annual Capex Investment Of Rs 200 Crores To Rs 250 Crores
Equity
SYMBIOTEC
Symbiotec Pharmalab expects milestone cash flows in second half of FY27
Equity
SYMBIOTEC
Symbiotec Pharmalab expects elevated new business expenses to pressure profitability
Equity
SYMBIOTEC
Symbiotec Pharmalab Targets Revenue And EBITDA Growth In Current Fiscal Year
Equity
India US Trade Talks Continue In Positive Direction Says Trade Minister Goyal
Broader Market
Hikal Begins Panoli Production For Global Personal Care Ingredients
Equity
HIKAL
Borosil Scientific Approves Bharuch Glassware Facility Expansion To Raise Annual Production
Equity
BOROSCI
HDFC Bank Reports Rs 16.39 Crores BSE Block Trade Involving 220350 Shares
Equity
HDFCBANK
PC Jeweller Repays Debt To Eleven Consortium Banks Ahead Of Schedule
Equity
PCJEWELLER
BPCL Reports NSE Block Trade Worth Rs 75.24 Crores Involving 2,413,410 Shares
Equity
BPCL
Bajaj Finance Reports Rs 22.22 Crores NSE Block Trade At Rs 1010.20
Equity
BAJFINANCE

